Skip to main content
Premium Trial:

Request an Annual Quote

Premaitha Health Receives Accreditation from English Regulator for NIPT Lab

NEW YORK (GenomeWeb) – Premaitha Health has received accreditation for its new noninvasive prenatal testing laboratory in Manchester from the Care Quality Commission, a regulator of health and care services in England.

Premaitha's clinical laboratory, based in the Manchester Science Park, will provide testing services on an interim basis for customers who are in the process of establishing the company's Iona test in their own laboratory. In addition, the lab will provide back-up services for customers during busy periods.

"We want to be able to offer a clinical laboratory service to support customers keen to provide the Iona test at the earliest possible opportunity," said Premaitha CEO Stephen Little in a statement. "The accreditation validates the quality of our facilities and the expertise of our clinical scientists."

Premaitha has licensed the CE-marked Iona test to a number of clinical laboratories in the UK and elsewhere in Europe.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.